9:00

Registration, networking and expo

Get your badge and join attendees for pre-conference networking and coffee while visiting the MaRS Impact...

Get your badge and join attendees for pre-conference networking and coffee while visiting the MaRS Impact Health expo.

10:00

Welcome and opening remarks

What to look forward to on day one of MaRS Impact Health.

What to look forward to on day one of MaRS Impact Health.

10:15

Opening keynote: Biotech market update from Jon Norris

Insights from the managing director of innovation banking at HSBC on how today’s biotech funding environment...

Insights from the managing director of innovation banking at HSBC on how today’s biotech funding environment is impacting early-stage ventures.

10:35

Lightning Talk: mRNA meets Gen AI

How foundation models of biology can fix Eroom’s Law, the observation that the cost of developing...

How foundation models of biology can fix Eroom’s Law, the observation that the cost of developing a new drug is becoming increasingly expensive.

10:50

Startup pitch: Biotech ventures

 

 

12:00

Lunch break, networking and expo showcase

 

 

Networking (Provided by Stem Cell Network Canada)

 

 

12:15

Expo stage: Startup pitch — Digital health and medical device ventures

 

 

1:00

Navigating post-launch complexities: Closing care gaps

How can AI and advanced analytics help identify the right patients for treatment, flag early indicators...

How can AI and advanced analytics help identify the right patients for treatment, flag early indicators of disease and close care gaps? Hear from ventures and adopters in this rapidly-developing field.

1:30

Precision oncology’s funding frenzy

The science isn’t new, but the deal volume is. Antibody-drug conjugates and radiotherapies target cancerous cells...

The science isn’t new, but the deal volume is. Antibody-drug conjugates and radiotherapies target cancerous cells while minimizing the effects of traditional chemo — and innovators in this space are making major strides and landing even bigger deals. This panel will explore what’s driving the recent interest, the market opportunity for these complex treatments in Canada versus the U.S., the platforms supporting researchers, as well as the economic, efficacy and safety challenges that remain.

2:00

Scaling an in vivo CRISPR therapy using fruit flies

In 2023, we saw the first-ever approval of a medicine based on CRISPR technology, which is...

In 2023, we saw the first-ever approval of a medicine based on CRISPR technology, which is leading the way for new in vivo therapies, as well as treatments based on more efficient genome editors. This session features Jenthera and Future Fields.

2:20

Meet your twin: Digital twins and the potential for personalized medicine

Digital twins are virtual duplicates created to demonstrate how systems change when new variables are introduced....

Digital twins are virtual duplicates created to demonstrate how systems change when new variables are introduced. For startups Verto and Altis Labs, digital twins can speed up drug development as AI surrogates for clinical trials, provide synthetic cancer genomes and deliver public health insights by testing population impacts.

2:45

Coffee break, structured networking sessions and expo showcase

 

 

Workshop: Sustainable care — creating low carbon health systems

Did you know that healthcare is among the top five biggest global polluters? Discover how leading...

Did you know that healthcare is among the top five biggest global polluters? Discover how leading healthcare entities like the Canadian Medical Association (CMA) and UHN are spearheading initiatives towards carbon neutrality. Learn about their efforts to reach net zero, from energy-efficient infrastructure to waste reduction programs, and delve into the transformative impact these measures are having on both environmental sustainability and patient care.

Expo stage: Startup pitch: Digital health and medical device ventures (Part 2)

 

 

3:30

Navigating Investments in Biopharma: Models for Innovation

How are pharma companies prioritizing and constructing new drug pipelines? What are the novel models for...

How are pharma companies prioritizing and constructing new drug pipelines? What are the novel models for funding and supporting development? Hear from the innovation arms of several biopharmaceutical companies sharing their business development strategies and how biotech startups can win.

4:00

Alán Aspuru-Guzik: AI + self-driving labs

The U of T professor and head of the Acceleration Consortium will walk us through the...

The U of T professor and head of the Acceleration Consortium will walk us through the first successful application of AlphaFold, an AI system that predicts a protein’s 3D structure from its amino acid sequence, to accelerate the design of a novel drug for liver cancer.

4:10

AI-enabled drug discovery: Therapeutics as a service

This discussion will explore venture investment in biotech and the growth of AI-driven platforms for drug...

This discussion will explore venture investment in biotech and the growth of AI-driven platforms for drug discovery.

4:30

The frontiers of generative biology with Flagship Pioneering

With the help of generative AI and machine intelligence, we are making progress in better understanding...

With the help of generative AI and machine intelligence, we are making progress in better understanding the codes of life (DNA, RNA and proteins), and the implications for how we design and generate new medicines and materials will be profound. Flagship Pioneering general partner Geoffrey von Maltzahn closes out day one of MaRS Impact Health, describing some of the company’s innovations on the frontiers of generative biology, including diverse technologies as protein design, gene writing, and somatic genetics in human health and sustainability.

4:55

Closing remarks

 

 

9:00

Registration, networking and expo

Join attendees for pre-conference networking and coffee while visiting the MaRS Impact Health expo.

Join attendees for pre-conference networking and coffee while visiting the MaRS Impact Health expo.

10:00

Day Two: Opening remarks and vital signs

What to look forward to on day two of MaRS Impact Health, followed by a short...

What to look forward to on day two of MaRS Impact Health, followed by a short pulse check on innovation in the device and digital health sectors.

10:15

Opening keynote from Brittany Barreto: Advancing women’s health innovation

Brittany Barreto will explore the landscape of women’s health innovation, drawing on her unique background as...

Brittany Barreto will explore the landscape of women’s health innovation, drawing on her unique background as a scientist and entrepreneur. With a focus on technology and investment, she’ll discuss practical strategies for advancing FemTech and transforming healthcare for women globally.

10:30

Closing the gap for women's health

For too long, male physiology has informed health care for women. It’s time that women’s health...

For too long, male physiology has informed health care for women. It’s time that women’s health be viewed as more than a niche market and not just through the narrow lens of reproductive health. This panel delves into ongoing gaps and why it’s critical that investors prioritize women’s health innovation.

10:55

Announcement: Accelerating AI-powered healthcare applications

Bayer and Google Cloud announce a collaboration focused on development of artificial intelligence solutions to support...

Bayer and Google Cloud announce a collaboration focused on development of artificial intelligence solutions to support radiologists.

11:05

Panel: Medical imaging evolution: Advancing therapies and diagnostics

Imaging data accounts for about 90 percent of all healthcare data. This makes it one of...

Imaging data accounts for about 90 percent of all healthcare data. This makes it one of the most important sources of clinical evidence for diagnosis and managing patient conditions. How might AI solutions support the handling, analysis and interpretation of medical imaging data? What do these tools look like when applied in clinical practice? How can Canada’s health systems adopt AI and deploy it in a way that helps radiologists and other clinicians who are under pressure and under-resourced? This panel will explore advances in novel AI-powered medical imaging technologies and pathways towards market adoption for impactful outcomes.

11:30

Fireside with Rishi Nayyar, co-founder and CEO, PocketHealth

Hear from the CEO of PocketHealth on their goals to improve patient-centered care by providing seamless...

Hear from the CEO of PocketHealth on their goals to improve patient-centered care by providing seamless access to medical imaging and reports.

11:45

Startup pitch: Digital health ventures

 

 

12:45

Lunch break, networking, workshops and expo showcase

 

 

Workshop: Closing patient care gaps with AI

AI-driven healthcare solutions have been in the works for years, but the direct patient impacts are...

AI-driven healthcare solutions have been in the works for years, but the direct patient impacts are still limited. In this panel, we hear how healthcare experts are navigating the challenges of implementing and using AI in clinical practice with insights that can be applied in any field.

Workshop: Developing digital health solutions and drugs more efficiently

Explore AI-powered apps that assist radiologists, reduce burnout and support more efficient diagnoses. This workshop is...

Explore AI-powered apps that assist radiologists, reduce burnout and support more efficient diagnoses. This workshop is presented by Bayer and Google Cloud.

Expo stage: Startup pitch: Biotech ventures

 

 

Networking (Provided by Stem Cell Network Canada)

 

 

1:45

Brain CODE: How much data is enough data?

Join the Ontario Brain Institute’s Centre for Analytics for a session showcasing pioneering neurotechnology ventures and...

Join the Ontario Brain Institute’s Centre for Analytics for a session showcasing pioneering neurotechnology ventures and research, culminating in a panel discussion delving into data in the realm of precision neuroscience.

2:20

Fireside with Ben Nashman, founder and CEO, Synex Medical

As of now, there are no commercially-available devices that measure blood glucose non-invasively. Learn how Synex...

As of now, there are no commercially-available devices that measure blood glucose non-invasively. Learn how Synex Medical is attempting to solve for this.

2:35

Active mobility and the growing need for assistive technology

People living with disabilities often can’t get the assistive devices they need, and startups in this...

People living with disabilities often can’t get the assistive devices they need, and startups in this space face numerous barriers when commercializing these solutions. This panel features several experts navigating and supporting ventures as they tackle these scaling challenges.

3:00

Coffee break, structured networking sessions and expo showcase

Expo: Seed and pre-seed ventures – digital health & devices

Expo: Seed and pre-seed ventures – digital health & devices

Workshop: Mind balance — Founder mental health

A founder’s mental well-being is a critical determinant of startup success. Limited access to mental health...

A founder’s mental well-being is a critical determinant of startup success. Limited access to mental health support is an added challenge for founders and their teams. This session will discuss the results of a recent survey conducted by MaRS and District 3.

Workshop: Supporting early stage healthtech ventures

Fewer than one-third of companies make it past the first five years and if they do,...

Fewer than one-third of companies make it past the first five years and if they do, it’s even harder to scale. For healthtech ventures, securing investment often means proving a product or application has meaningful clinical impact. Clinical validation implies that startups can test their solutions in a real healthcare setting, something that isn’t currently possible in Canada. This panel will explore opportunities and resources for the health system to better support healthtech ventures in Canada.

3:35

Startup pitch: Device ventures

 

 

4:35

Closing keynote

 

 

5:00

Closing reception: Celebrating health founders

That’s a wrap! Join us for a closing reception as we celebrate MaRS Impact Health 2024...

That’s a wrap! Join us for a closing reception as we celebrate MaRS Impact Health 2024 and its founders, entrepreneurs, partners and speakers.